Why the study?
Epicardial adipose tissue may mediate cardiac involvement in systemic sclerosis, but its correlation with left ventricular function and prognostic value remained to be determined.
Does epicardial adipose tissue correlate with left ventricular function and predict mortality in patients with systemic sclerosis?
Does epicardial adipose tissue correlate with left ventricular function and predict mortality in patients with systemic sclerosis?
In patients with systemic sclerosis, epicardial adipose tissue is independently associated with left ventricular diastolic dysfunction and increased all-cause mortality.
Answers are grounded in this paper and cite their sources.
EAT may aid mortality risk stratification in systemic sclerosis; leaves open whether it adds value beyond standard markers in prospective studies.
Aims: Epicardial adipose tissue (EAT) has emerged as a mediator between systemic inflammatory disorders and cardiovascular disease, and may therefore play a role in the pathophysiology of cardiac involvement in systemic sclerosis (SSc). The aim of this study was to assess the correlation between EAT and left ventricular (LV) function, and to determine the prognostic value of EAT in patients with SSc. Methods and In the multivariable analysis, EAT was independently associated with all-cause mortality after adjusting for important covariates (HR: 1.006; 95% CI: 1.001-1.010). Conclusion: In patients with SSc, EAT is independently associated with LV diastolic dysfunction and higher mortality rate.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: